Indivior Pharmaceuticals (INDV) Profit After Tax (2024 - 2026)
Indivior Pharmaceuticals' Profit After Tax was $122 million in Q2 2026, up 577.8% from $18 million a year earlier and up 37.1% from the prior quarter.
Powered by 
Analysis
Indivior Pharmaceuticals (INDV) Profit After Tax (2024 - 2026) Analysis & Trends
On a trailing twelve-month basis, Indivior Pharmaceuticals' Profit After Tax was $355 million through Jun 30, 2026, up 225.7% year-over-year; for FY2025, it came in at $210 million.
- Profit After Tax shows a four-year compound annual growth rate of 0.6% (FY2021 to FY2025).
- In earlier years, Profit After Tax was $7 million in FY2024, -$126 million in FY2023, -$43 million in FY2022 and $205 million in FY2021.
- The Q2 2026 figure marks the highest quarterly Profit After Tax in data going back to Q1 2024.
- Compared with a year earlier, Profit After Tax has increased for four straight quarters, with growth averaging 223.4% over the last five quarters.
- Per Business Quant data, INDV's Profit After Tax in the three quarters before Q2 2026 was $89 million (Q1 2026), $102 million (Q4 2025) and $42 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 5.53 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 3.62 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | -1.34 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 5.28 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 3.09 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 2.38 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -10.50 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | -246.00 Mn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 1.10 Bn |
| 10 | Indivior Pharmaceuticals | 4.23 Bn | 3.19 Bn | 294.00 Mn | 122.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 122.00 Mn |
| Mar 31, 2026 | 89.00 Mn |
| Dec 31, 2025 | 102.00 Mn |
| Sep 30, 2025 | 42.00 Mn |
| Jun 30, 2025 | 18.00 Mn |
| Mar 31, 2025 | 48.00 Mn |
| Dec 31, 2024 | 21.00 Mn |
| Sep 30, 2024 | 22.00 Mn |
| Jun 30, 2024 | -98.00 Mn |
| Mar 31, 2024 | 62.00 Mn |
API Access
Indivior Pharmaceuticals Profit After Tax API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=profit-after-tax&ticker=INDV&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "profit-after-tax", "ticker": "INDV", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=profit-after-tax&ticker=INDV&period=max&api_key=YOUR_API_KEY");
const data = await res.json();